Search results for: HTA

Comparing Preference-based Outcome Measures for Overactive Bladder: EQ-5D-5L vs OAB-5D

31 January 2018

…on the OAB-5D, a condition-specific preference-based measure (PBM) of health. Cost-utility analysis forms an integral part of health technology assessment (HTA) in a growing number of countries. Societal preferences for…

OHE at ISPOR 2018

16 May 2018

…preference information in HTA.   Poster: Comparing the EQ-5D-3L and EQ-5D-5L in a Cohort of Cancer Patients   Paula Lorgelly will present this poster – co-authored with OHE’s Patricia Cubi-Molla;…

A Critique of Hill et al. (2018) on Estimated Costs of Production for the WHO Essential Medicines List

19 May 2018

…R&D cost is both to be expected and is necessary. Health Technology Assessment (HTA) is the tool that can inform price negotiation or decisions about use of a product. In…

2022 Innovation Policy Prize

…greater. Economic evaluations of medicines form an important component of health technology assessment (HTA) processes [4]. These are increasingly used during negotiations over the prices of new medicines between payers and manufacturers [5]….

Andrés Pichon-Riviere

8 June 2025

…a PhD in Public Health (UBA). Andres is the Director of the Health Economics and Technology Assessment Department and the WHO/PAHO collaborating center in HTA at the Institute for Clinical…

The Broader Value of Existing Vaccines in the Fight Against COVID-19: Beware of Tunnel Vision

8 October 2020

As the world is figuring out how to deal with COVID-19, it is worth taking stock of the broader value that existing vaccines bring to societies suffering from this pandemic….

How to Analyse EQ-5D Data? Methods for Analysing and Reporting EQ-5D Data: The Indispensable New Guide

8 December 2020

…recently – in routine data collection in health care systems. (…) EQ-5D has become the cornerstone of health technology appraisal (HTA), affecting important decisions about access to new medicines. But despite…

Time to Tackle the Challenges around Combination Therapies for Cancer

29 March 2021

…to be addressed here include the role that an HTA or Payer body could and should play in instigating or joining negotiations between manufacturers, and the ways in which such…

Towards a New Understanding of Unmet Medical Need

22 June 2021

…a lack of alignment in the way it is interpreted by different stakeholders (including public research funders, health regulators, and health technology assessment (HTA) agencies) in terms of priority-setting. A…